SARS

Experimental SARS vaccine shows promise in mice

Published in TB and Outbreaks Week, April 20th, 2004

An experimental SARS vaccine protected mice against the respiratory illness that killed nearly 800 people worldwide last year, but a safe and effective vaccine for humans is probably still a long way off.

Results published in the April 1, 2004, issue of the journal Nature show the vaccine triggered an immune response in the mice and dramatically reduced the level of the virus in the lungs of inoculated mice.

But researchers at the U.S. National Institute of Allergy and Infectious Diseases, which developed the gene-based vaccine, said more experiments are needed to determine if it will work in humans.

Scientists not involved...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2004-04-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry